video corpo

LT630 Monitoring EQA Performance
1 / 1ページ

{{requestButtons}}

カタログの抜粋

LT630 Monitoring EQA Performance - 1

Monitoring EQA Performance : Investigating the source of the problem In order to identify the source of the problem it is useful to be aware of the most common causes of poor EQA performance. Errors can occur at any stage of the testing process however EQA is most concerned with detecting analytical errors i.e. errors that occur during the analysis of the sample. Most analytical errors can be easily divided into three main areas; clerical errors, systematic errors and random errors. Systematic errors result in inaccurate results that consistently show a positive or negative bias. Random errors on the other hand affect precision and result in fluctuations in either direction. The flowchart (below) is designed to help you investigate any apparent poor performance. Is the parameter result within acceptable limits of performance? YES • Target Score >50 • SDI <2SDPA • % Deviation < acceptable limits of performance Send corrected result to RIQAS along with relevant documentation to support the case. Verify instrument, method and units are registered correctly for each parameter. Especially important for initial submission and when registration changes have been made. Review the summary page. Are the majority of results flagged? Advise RIQAS of correct details Review Levey-Jennings charts. Are any points outside +/- 1SD? Review instrument parameters and calibration. Has the reagent batch been changed? Review IQC results from the time the EQA sample was tested. Look for trends within the data • Positive/Negative bias • Poor precision • Changes in performance due to change in reagent, calibrator or standardisation There may be a problem specific to that sample • Incorrect sample tested • Reconstitution error • Sample storage Look for shifts or trends Investigate and take corrective action The largest global EQA scheme QUALITY CONTROL Information correct at time of print. Randox Laboratories Ltd is a subsidiary of Randox Holdings Limited a company registered within Northern Ireland with company number N.I. 614690. VAT Registered Number: GB 151 6827 08. Product availability may vary from country to country. Please contact your local Randox representative for information. Products may be for Research Use Only and not for use in diagnostic procedures in the USA. Review performance over the cycle Verify that the reported result and units reflect what was obtained. Has a transcription

カタログの1ページ目を開く

Randox Laboratories/ランドックスのすべてのカタログと技術パンフレット

  1. Acusera 24.7

    24 ページ

  2. Company Overview

    40 ページ

  3. Reagents Brochure

    64 ページ

  4. sdLDL-C

    8 ページ

  5. RX modena

    20 ページ

  6. RX misano

    20 ページ

  7. RX Daytona Plus

    20 ページ

  8. Rx Imola

    20 ページ

  9. RX Monaco

    20 ページ

  10. 2024 Product List

    64 ページ

  11. VeraSTAT-V

    16 ページ

  12. VERASTAT

    16 ページ

  13. Endocrine Array

    4 ページ

  14. Cerebral Arrays

    4 ページ

  15. Thyroid Arrays

    4 ページ

  16. Basic QC Stastics

    8 ページ

  17. Qnostics

    52 ページ

  18. Adiponectin LT519

    28 ページ

  19. Specific Proteins

    40 ページ

  20. Linearity sets

    12 ページ

  21. Antioxidants

    16 ページ

  22. Diabetes Portfolio

    28 ページ

  23. Total Bile Acids

    4 ページ

  24. VIVALYTIC

    30 ページ

  25. RANDOX DISCOVERY

    36 ページ

  26. HbA1c

    2 ページ

  27. Preparing QC

    1 ページ

カタログアーカイブ

  1. ACUSERA

    108 ページ

  2. Evidence Evolution

    28 ページ

  3. Evidence

    16 ページ

  4. Molecular Testing

    16 ページ

  5. Fertility Array

    4 ページ

  6. Rx Daytona

    16 ページ

  7. Evidence

    16 ページ